Kontora participates in oncology research company Indivumed
A team led by Fabian G. Gaffron, Partner at Heuking Kühn Lüer Wojtek, advised a Kontora fund set up for this purpose on its participation in a capital increase at Indivumed GmbH. Legal and tax advice on the structuring of the special AIF managed by Kontora Kapitalverwaltungs GmbH was also provided by a team led by Dr. Michael Dröge and Fabian G. Gaffron.
Oncology research company Indivumed offers a worldwide leading tumor database in cancer research, which allows for individual, personalized therapies and drugs. With the successful launch of new products, Indivumed is about to take a major expansion step.
Indivumed GmbH was founded in 2002 with a drive to revolutionize cancer treatment through individualized therapy. The physician-led company maintains the world’s premier multi-omics oncology database and biobank to support cancer research and to develop new diagnostics and therapies for cancer. Indivumed is headquartered in Hamburg, Germany, with a US-based subsidiary and a global clinical network.
Hamburg-based Kontora is an independent multi-family office for individual advice and implementation of wealth strategies. Using a holistic consulting approach, Kontora creates transparent individual and complex asset structures.
Counsel to Kontora:
Advice on acquisition and structuring of the special AIF:
Fabian G. Gaffron (Lead, M&A and Tax)
Dr. Michael Dröge (Investment Funds)
Julia Cramer (Investment Funds)
Sven Johannsen (Investment Funds and Due Diligence)
Dr. Sarah Slavik-Schulz (Project Coordination Due Diligence, Tax and Corporate), all Hamburg
Dr. Johan-Michael Menke, LL.M. (Employment)
Dr. Kai Erhardt (Financing)
Dr. Sabine Ottow (Corporate, Transparency Register)
Lena Sieven (Corporate)
Viktoria W. Kämper (Real Estate), all Hamburg
Jens Blumrich (IT), Chemnitz
Tim Remmel, LL.M. (Commercial/Contracts), Cologne
Britta Hinzpeter, LL.M. (Data Protection, Commercial/Contracts)
Peter Michael Schäffler (Tax), both Munich
Astrid Luedtke (IP), Düsseldorf